Bone targeted compounds and methods are provided. Compounds can include a Bone Targeting Portion (R
T
), having an affinity for bone; a Bone Active Portion (R
A
) for interacting with and affecting bone; a Linking Portion (R
L
) connecting the Bone Targeting Portion and the Bone Active Portion. The Bone Active Portion is derived from an estrogenic agent. Compounds can also include a Blocking Group (R
P
) that reduces or eliminates the estrogenic activity of the Bone Active Portion.
提供了针对骨骼的化合物和方法。这些化合物可以包括针对骨骼的部分(RT),具有与骨骼的亲和力;用于与骨骼相互作用并影响骨骼的活性部分(RA);连接针对骨骼部分和活性部分的连接部分(RL)。活性部分来源于
雌激素类药物。化合物还可以包括减少或消除活性部分
雌激素活性的阻断基团(RP)。